SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 30.70-2.8%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (484)3/7/2010 3:58:31 PM
From: Steve Lokness  Read Replies (1) of 566
 
Who knows what he means by low.

Listen to the CC - not so sure it is low relative to other like deals.

Question;
What does it mean when they say ......AstraZeneca will be responsable for "all development, regulatory and commercialization activities"? Does that mean that AZN takes over and Rigel is done with working with the drug - or does it mean that AZN pays to Rigel for their continuing work? And if they pay Rigel, what gets covered here? For instance, does a portion of cost for Rigel management get picked up?

steve
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext